Effects of Immunosuppressants on Immune Response to Vaccine in Inflammatory Bowel Disease
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
General Medicine
Reference37 articles.
1. 5-aminosalicylic acid is not protective against colorectal cancer in inflammatory bowel disease: A meta-analysis of non-referral populations;Nguyen;Am J Gastroenterol,2012
2. Triad of severe abdominal pain, inappropriate antidiuretic hormone secretion, and disseminated varicella-zoster virus infection preceding cutaneous manifestations after hematopoietic stem cell transplantation: Utility of PCR for early recognition and therapy;Rau;Pediatr Infect Dis J,2008
3. The second European evidence-based consensus on the diagnosis and management of Crohn's disease: Current management;Dignass;J Crohns Colitis,2010
4. Infliximab, azathioprine, or combination therapy for Crohn's disease;Ruffolo;N Engl J Med,2010
5. Patients with inflammatory bowel disease have a lower response rate to HBV vaccination compared to controls;Altunöz;Dig Dis Sci,2012
Cited by 14 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Serum Anti-Spike Antibodies Are Not Affected by Immunosuppressants in SARS-CoV-2 Vaccinations Given to Brazilian Patients with Inflammatory Bowel Disease;Healthcare;2023-10-19
2. Humoral immunity improves with a booster dose of SARS-CoV-2 vaccine in patients with inflammatory bowel disease on immunosuppressants;2023-04-03
3. Gastrointestinal dysbiosis and Escherichia coli pathobionts in inflammatory bowel diseases;APMIS;2022-07-27
4. Response to SARS-CoV-2 vaccination in systemic autoimmune rheumatic disease depends on immunosuppressive regimen: a matched, prospective cohort study;Annals of the Rheumatic Diseases;2022-03-18
5. Early humoral immune response to two doses of severe acute respiratory syndrome coronavirus 2 vaccine in a diverse group of solid organ transplant candidates and recipients;Clinical Transplantation;2022-02-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3